Monopar Therapeutics SEC filings MNPR
Monopar Therapeutics has 536 filings in SEC EDGAR's recent list, going back to Jun 18, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | Form s-8 pos | Jul 22, 2026 | — |
| S-8 POS | Form s-8 pos | Jul 22, 2026 | — |
| S-8 POS | Form s-8 pos | Jul 22, 2026 | — |
| S-8 POS | Form s-8 pos | Jul 22, 2026 | — |
| S-8 | Employee stock plan registration | Jul 22, 2026 | — |
| 424B5 | Prospectus supplement | Sep 24, 2025 | — |
| S-3 | Shelf registration | Aug 29, 2025 | — |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 424B3 | Prospectus | Jan 27, 2025 | — |
| S-3 | Shelf registration | Jan 15, 2025 | — |
| 424B5 | Prospectus supplement | Dec 23, 2024 | — |
| 424B3 | Prospectus | Dec 18, 2024 | — |
| S-3 | Shelf registration | Nov 29, 2024 | — |
| 424B5 | Prospectus supplement | Oct 29, 2024 | — |
| 424B5 | Prospectus supplement | Oct 28, 2024 | — |
| 424B5 | Prospectus supplement | Jan 4, 2023 | — |
| S-3 | Shelf registration | Dec 21, 2022 | — |
| S-8 | Employee stock plan registration | Aug 12, 2022 | — |
| 424B5 | Prospectus supplement | Apr 20, 2022 | — |
| S-8 | Employee stock plan registration | Nov 13, 2020 | — |
| 424B5 | Prospectus supplement | Jan 13, 2020 | — |
| S-3 | Shelf registration | Jan 3, 2020 | — |
| S-8 | Employee stock plan registration | Jan 3, 2020 | — |
| 424B4 | Prospectus | Dec 19, 2019 | — |
| S-1/A | Amended registration statement | Dec 13, 2019 | — |
| S-1/A | Amended registration statement | Nov 4, 2019 | — |
| S-1/A | Amended registration statement | Nov 4, 2019 | — |
| S-1/A | Amended registration statement | Oct 1, 2019 | — |
| FWP | Free writing prospectus | Sep 23, 2019 | — |
| S-1/A | Amended registration statement | Sep 13, 2019 | — |
| S-1/A | Amended registration statement | Sep 10, 2019 | — |
| S-1 | Registration statement | Aug 15, 2019 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MNPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmette, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1645469
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.